Search Results - "Shmidt, Evgeniya"
-
1
TCR repertoire profiling revealed antigen-driven CD8+ T cell clonal groups shared in synovial fluid of patients with spondyloarthritis
Published in Frontiers in immunology (17-10-2022)“…Spondyloarthritis (SpA) comprises a number of inflammatory rheumatic diseases with overlapping clinical manifestations. Strong association with several HLA-I…”
Get full text
Journal Article -
2
CD8+ T cells with characteristic T cell receptor beta motif are detected in blood and expanded in synovial fluid of ankylosing spondylitis patients
Published in Rheumatology (Oxford, England) (01-06-2018)“…Abstract Objective The risk of AS is associated with genomic variants related to antigen presentation and specific cytokine signalling pathways, suggesting the…”
Get full text
Journal Article -
3
Treatment of acute pulmonary embolism after catheter-directed thrombolysis with dabigatran vs warfarin: Results of a multicenter randomized RE-SPIRE trial
Published in Journal of vascular surgery. Venous and lymphatic disorders (New York, NY) (01-07-2024)“…Thrombolytic therapy is effective method in the high-risk acute pulmonary embolism (PE) treatment. Reduced-dose thrombolysis (RDT) plus oral anticoagulation…”
Get full text
Journal Article -
4
Circulating CD35− /CD49d+ neutrophils in influenza virus infection patients
Published in Human immunology (01-11-2012)“…Abstract Release of immature neutrophils from bone marrow into circulation accompanies acute inflammatory states. Previous studies have identified a number of…”
Get full text
Journal Article -
5
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Published in The Lancet (British edition) (08-12-2018)“…Biological disease-modifying anti-rheumatic drugs (bDMARDs) are recommended for radiographic axial spondyloarthritis, otherwise known as ankylosing…”
Get full text
Journal Article -
6
Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study
Published in Nutrition research (New York, N.Y.) (01-05-2009)“…Abstract Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal…”
Get full text
Journal Article -
7
Clinical significance of the direct analgesic effect of targeted medications in patients with rheumatoid arthritis
Published in РМЖ: Медицинское обозрение (2020)“…Aim: to evaluate the possibility of clinically significant analgesic effect of tofacitinib in patients with rheumatoid arthritis (RA) under the conditions of…”
Get full text
Journal Article